Share This Article:

A Simple Procedure for Termination of Pregnancy in the Late First Trimester with Mifeprostone and Misoprostol

Abstract Full-Text HTML XML Download Download as PDF (Size:357KB) PP. 573-579
DOI: 10.4236/ojog.2015.511081    2,031 Downloads   2,696 Views  

ABSTRACT

Purpose: To assess the efficacy of medical methods for termination of pregnancy at 9 - 12 weeks of gestation. Methods: Between December 2008 and December 2010, the 116 consecutive women received 200 mg oral mifepristone and after 24 - 36 hours they applied 800 μg vaginal misoprostol to medically terminate pregnancy. If the products of conception did not pass, three further doses of 400 μg misoprostol were given vaginally at three hours intervals to medically terminate pregnancy. Results: Of the 116 patients undergoing the procedure 104 (90%) aborted completely. Half of the patients aborted within 6 hours. After medical termination, five per cent of the women were treated because of infection, and five per cent needed a revisit to hospital because of excessive bleeding. Two women received a blood transfusion. Previous live births or previous inducted abortion is presented in the study results. Conclusions: Medical abortion at 9 - 12 weeks’ gestation is a safe alternative to surgery.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Joensuu-Manninen, H. , Nissi, R. , Santala, M. and Talvensaari-Mattila, A. (2015) A Simple Procedure for Termination of Pregnancy in the Late First Trimester with Mifeprostone and Misoprostol. Open Journal of Obstetrics and Gynecology, 5, 573-579. doi: 10.4236/ojog.2015.511081.

References

[1] WHO (2003) Safe Abortion. Technical and Policy Guidance for Health Systems. Geneva.
http://whqlibdoc.who.int/publications/2003/9241590343.pdf
[2] Sedgh, G., Singh, S., Shah, I.H., Ahman, E., Henshaw S.K. and Bankole A. (2012) Induced Abortion: Incidence and Trends Worldwide from 1995 to 2008. The Lancet, 379, 625-632.
http://dx.doi.org/10.1016/S0140-6736(11)61786-8
[3] Kulier, R., Kapp, N., Gülmezoglu, A.M., Hofmeyr, G.J., Cheng, L. and Campana, A. (2011) Medical Methods for First Trimester Abortion. Cochrane Database of Systematic Reviews, 11, Article ID: CD002855.
http://dx.doi.org/10.1002/14651858.cd002855.pub4
[4] Colleselli, V., Schreiber, C. and Mangesius, S. (2014) Medical Management of Early Pregnancy Failure (EPF): A Retrospective Analysis of a Combined Protocol of Mifepristone and Misoprostol Used in Clinical Practice. Archives of Gynecology and Obstetrics, 289, 1341-1345.
http://dx.doi.org/10.1007/s00404-013-3105-4
[5] Tendler, R., Bornstein, J. and Kais, M. (2015) Early versus Late Misoprostol Administration after Mifepristone for Medical Abortion. Archives of Gynecology and Obstetrics. (In Press)
http://dx.doi.org/10.1007/s00404-015-3722-1
[6] von Hertzen, H., Piaggio, G. and Wojdyla, D. (2009) WHO Research Group on Post-Ovulatory Methods of Fertility Regulation. Two Mifepristone Doses and Two Intervals of Misoprostol Administration for Termination of Early Pregnancy: A Randomised Factorial Controlled Equivalence Trial. BJOG, 116, 381-389.
http://dx.doi.org/10.1111/j.1471-0528.2008.02034.x
[7] Augustin, G., Majerovic, M. and Luetic, T. (2013) Uterine Perforation as a Complication of Surgical Abortion Causing Small Bowel Obstruction: A Review. Archives of Gynecology and Obstetrics, 288, 311-323.
http://dx.doi.org/10.1007/s00404-013-2749-4
[8] Royal College of Obstetricians and Gynaecologists (2001) The Care of Women Requesting Induced Abortion, Evidence-Based Clinical Guideline Number 7. RCOG Press, London.
https://www.rcog.org.uk/globalassets/documents/guidelines/abortion-guideline_web_1.pdf
[9] Pazol, K., Zane, S.B., Parker, W.Y., Hall, L.R., Berg, C. and Cook, D.A. (2011) Medical Abortion at 63 to 90 Days of Gestation. MMWR Surveillance Summaries, 60, 1-41.
[10] Lokeland, M., Iversen, O.E., Dahle, G.S., Nappen, M.H., Ertzeid, L. and Bjorge, L. (2010) Medical Abortion at 63 to 90 Days of Gestation. Obstetrics & Gynecology, 115, 962-968.
http://dx.doi.org/10.1097/AOG.0b013e3181da0c3e
[11] Woldetsadik, M.A., Sendekie, T.Y., White, M.T. and Zegeye, D.T. (2011) Client Preferences and Acceptability for Medical Abortion and MVA as Early Pregnancy Termination Method in Northwest Ethiopia. Reproductive Health, 8, 19-21.
http://dx.doi.org/10.1186/1742-4755-8-19
[12] Ashok, P.W., Hamoda, H., Flett, G.M., Kidd, A., Fitzmaurice, A. and Templeton, A. (2005) Patient Preference in a Randomized Study Comparing Medical and Surgical Abortion at 10-13 Weeks Gestation. Contraception, 71, 143-148.
http://dx.doi.org/10.1016/j.contraception.2004.08.013
[13] Hamoda, H., Ashok, P.W., Flett, G.M. and Templeton, A. (2005) A Randomised Controlled Trial of Mifepristone in Combination with Misoprostol Administered Sublingually or Vaginally for Medical Abortion up to 13 Weeks of Gestation. BJOG, 112, 1102-1108.
http://dx.doi.org/10.1111/j.1471-0528.2005.00638.x
[14] Hamoda, H., Ashok, P.W., Flett, G.M. and Templeton, A. (2005) Medical Abortion at 9 - 13 Weeks’ Gestation: A Review of 1076 Consecutive Cases. Contraception, 71, 327-332.
http://dx.doi.org/10.1016/j.contraception.2004.10.015
[15] Patua, B., Dasgupta, M. and Kumar, S. (2013) An Approach to Evaluate the Efficacy of Vaginal Misoprostol Administrated for a Rapid Management of First Trimester Spontaneous Onset Incomplete Abortion, in Comparison to Surgical Curettage. Archives of Gynecology and Obstetrics, 288, 1243-1248.
http://dx.doi.org/10.1007/s00404-013-2894-9
[16] Official Statistics of Finland, Health (2011) Induced Abortions. THL—National Institute for Health and Welfare. Statistical Report 21/2012, 1.10.2012.
[17] Oppegaar, K.S., Qvigstad, E., Fiala, C., Heikinheimo, O., Benson, L. and Gemzell-Danielsson, K. (2015) Clinical Follow-Up Compared with Self-Assessment of Outcome after Medical Abortion: A Multicentre, Non-Inferiority, Randomised, Controlled Trial. Lancet, 385, 698-704.
http://dx.doi.org/10.1016/S0140-6736(14)61054-0
[18] Shaw, K.A., Topp, N.J., Shaw, J.G. and Blumenthal, P.D. (2013) Mifepristone-Misoprostol Dosing Interval and Effect of Induction Abortion Times: A Systematic Review. Obstetrics & Gynecology, 121, 1335-1347.
http://dx.doi.org/10.1097/AOG.0b013e3182932f37
[19] Bracken, H., Ngoc, N.T., Schaff, E., Coyaji, K., Ambardekar, S. and Westheimer, E. (2007) Mifepristone Followed in 24 Hours to 48 Hours by Misoprostol for Late First-Trimester Abortion. Obstetrics & Gynecology, 109, 895-901.
http://dx.doi.org/10.1097/01.AOG.0000259319.18958.76
[20] da Silva Dal Pizzol, T., Knop, F.P. and Mengue, S.S. (2006) Prenatal Exposure to Misoprostol and Congenital Anomalies: Systematic Review and Meta-Analysis. Reproductive Toxicology, 22, 666-671.
http://dx.doi.org/10.1016/j.reprotox.2006.03.015
[21] Bos-Thompson, M.A., Hillaire-Buys, D., Roux, C., Faillie, J.L. and Amram, D. (2008) Mobius Syndrome in a Neonate after Mifepristone and Misoprostol Elective Abortion Failure. Annals of Pharmacotherapy, 42, 888-892.
http://dx.doi.org/10.1345/aph.1K550
[22] Briegel, W. (2006) Neuropsychiatric Findings of Mobius Sequence. Clinical Genetics, 70, 91-97.
http://dx.doi.org/10.1111/j.1399-0004.2006.00649.x
[23] Verzijl, H.T., van der Zwaag, B., Cruysberg, J.R. and Padberg, G.W. (2003) Mobius Syndrome Redefined: A Syndrome of Rhombencephalic Maldevelopment. Neurology, 61, 327-333.
http://dx.doi.org/10.1212/01.WNL.0000076484.91275.CD
[24] Kaneshiro, B., Edelman, A., Sneeringer, R.K. and Ponce de Leon, R.G. (2011) Expanding Medical Abortion: Can Medical Abortion Be Effectively Provided without the Routine Use of Ultrasound? Contraception, 83, 194-201.
http://dx.doi.org/10.1016/j.contraception.2010.07.023

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.